5月19日,春立医疗(01858)午前上涨3.26%,报9.82港元。公司第一季度营收2.3亿元,同比增长3.6%,归母净利润5807.11万元,同比增5.2%。华创证券研报指出,集采影响逐渐减弱,公司重回增长轨道。今年前4个月,公司多个新产品获批,包括正畸支抗钉、骨组织手术设备等,进一步完善口腔与骨科产品线。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.